Literature DB >> 19320750

The application of bypassing-agent prophylaxis in haemophilia A patients with inhibitors: a meeting report.

L A Valentino1, M Carcao, P Mathew, C A Leissinger, E Berntorp, V Blanchette, C Escuriola-Ettingshausen, B Ewenstein, N Ewing, A Gringeri, W K Hoots, C Negrier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19320750     DOI： 10.1111/j.1365-2516.2008.01953.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  2 in total

Review 1.  Hemophilia and inhibitors: current treatment options and potential new therapeutic approaches.

Authors:  Shannon L Meeks; Glaivy Batsuli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

2.  First analysis of 10-year trends in national factor concentrates usage in haemophilia: data from CHARMS, the Canadian Hemophilia Assessment and Resource Management System.

Authors:  A N Traore; A K C Chan; K E Webert; N Heddle; B Ritchie; J St-Louis; J Teitel; D Lillicrap; A Iorio; I Walker
Journal:  Haemophilia       Date:  2014-07       Impact factor: 4.287
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.